Pharmaceutical Filtration Market outlook with industry review and forecasts | Trends 2018

The global market for pharmaceutical filtration is segmented on the basis of product, technique, application, scale of operation, and region. On the basis of product, the market for pharmaceutical filtration is segmented into membrane filters, prefilters and depth media filters, cartridge & capsule filters, single-use systems, filter holders, filtration accessories, and other products. In 2016, the membrane filters segment accounted for the largest share of the market. This segment is also expected to register the highest CAGR during the forecast period. The key factor driving the growth of the membrane filters segment is the ease of installation in large and small manufacturing facilities owing to the availability of a variety of pore and surface types.

Browse 87 market data Tables and 36 Figures spread through 164 Pages and in-depth TOC on "Pharmaceutical Filtration Market"

http://www.marketsandmarkets.com/Market-Reports/pharmaceutical-filtration-market-209343847.html

Early buyers will receive 10% customization on this report. 
Market growth is primarily driven by factors such as growing production of large molecules and biologics, technological advancements in nanofibers, growth in the generics market, and regulatory mandates for cleanrooms in pharmaceutical production. Other factors supporting market growth include an increase in R&D spending by biopharmaceutical companies to offer a strong biologics pipeline.
The global Pharmaceutical Filtration Market is segmented on the basis of product, technique, application, scale of operation, and region. On the basis of product, the Pharmaceutical Filtration Market is segmented into membrane filters, prefilters and depth media filters, cartridge & capsule filters, single-use systems, filter holders, filtration accessories, and other products.

Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=209343847

In 2016, the membrane filters segment accounted for the largest share of the market. This segment is also expected to register the highest CAGR during the forecast period. The key factor driving the growth of the membrane filters segment is the ease of installation in large and small manufacturing facilities owing to the availability of a variety of pore and surface types.
Based on application, the final product-processing segment is expected to register the highest CAGR during the forecast period owing to the rapidly growing biologics and generic drug production coupled with the presence of stringent regulatory guidelines to maintain a clean and safe manufacturing environment.

Talk To Our Research Analysts: http://www.marketsandmarkets.com/speaktoanalyst.asp?id=209343847

North America accounted for the largest share of the global Pharmaceutical Filtration Market in 2016, followed by Europe. Stringent regulatory guidelines to provide safe drugs is encouraging the use of pharmaceutical filtration products and the presence of a large number of market players are propelling the growth of the North American Pharmaceutical Filtration Market.

The Asian region is expected to register the highest CAGR in the forecast period. Growing investments in the biopharmaceutical industry and the rise in contract research and manufacturing organizations in emerging Asian countries are the key factors driving the growth of the Asian market.

The Pharmaceutical Filtration Market is dominated by established players such as Merck KGaA (Germany), GE Healthcare (U.S.), Pall Corporation (U.S.), Parker Hannifin Corporation (U.S.), and Sartorius Stedim Biotech S.A. (France).

Browse Related Reports: 
Pharmaceutical Membrane Filtration Market by Product (MCE, Coated Cellulose Acetate, Nylon, PVDF Membrane), Technique (Microfiltration, Ultra Filtration, Nanofiltration), Application (Final Product, Raw Material) - Global Forecast to 2021.
http://www.marketsandmarkets.com/Market-Reports/pharmaceutical-membrane-filtration-market-255408031.html

Laboratory Filtration Market by Technology (Ultrafiltration, Microfiltration, Nanofiltration, Reverse Osmosis), by Product (Assembly, Filter Paper, Membrane, Syringe Filters, Filtration Microplate, Accessories) & by End User - Global Forecast to 2021.
http://www.marketsandmarkets.com/Market-Reports/laboratory-filtration-market-12936082.html

About MarketsandMarkets: 
MarketsandMarkets provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. For more information, please visit http://www.marketsandmarkets.com

Contact:
Mr. Shelly
MarketsandMarkets
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Telephone No: 1-888-600-6441.
Email: sales@marketsandmarkets.com

Hematology Analyzers and Reagents Market Statistics and Research Analysis Released in latest Report

According to a new market research report "Hematology Analyzers and Reagents Market by Products & Services (Hematology Analyzers (5 Parts, 6 Parts, 3 Part, PoC, Semi-Automated), Hemostasis, Immunohematology), Price Range (High, Low), End User (Government labs) - Global Forecast to 2023", published by MarketsandMarkets™, the global market is projected to reach USD 4.98 Billion by 2023 from USD 3.31 Billion in 2018, at a CAGR of 8.5% during the forecast period.
    
Browse 76 market data Tables and 42 Figures spread through 169 Pages and in-depth TOC on "Hematology Analyzers and Reagents Market".

https://www.marketsandmarkets.com/Market-Reports/hematology-analyzers-reagents-market-153222146.html

Early buyers will receive 10% customization on this report
The increasing incidence of blood disorders and the growth in blood donation are the major factors driving the growth of the global hematology products market. Furthermore, factors such as technological advancements in hematology analyzers and reagents and integration of flow cytometry techniques with hematology analyzers are expected to support the growth of this market during the forecast period.

The hematology products and services segment is expected to register the highest growth rate during the forecast period
On the basis of products & services, the Hematology Analyzers and Reagents Market is classified into hematology, hemostasis, and immunohematology products and services. The hematology products and services segment is projected to grow at the highest growth rate during the forecast period. Factors such as the increasing adoption of POC testing hematology analyzers in emerging economies, launch of technologically advanced hematology products coupled with the increasing preference towards automation, the growing trend of the 'reagent rental' business model, and the rising availability of a wide range of services from major hematology providers, are driving the growth of this segment.

Ask for PDF Brochure : https://www.marketsandmarkets.com/pdfdownload.asp?id=153222146

Based on end user, the commercial service provider segment accounted for the largest share of the products and services market in 2017
By end user, the hematology products and services market is segmented into hospital laboratories, commercial service providers, government reference laboratories, and research & academic institutes. In 2017, the commercial service providers segment accounted for the largest share of the market due to the increasing awareness for hematology testing, shift from manual testing to automated testing, and competitive benefits offered by these providers as compared to hospitals (such as affordable service costs, efficient turnaround time, and efficient management for sample collection).

North America is expected to dominate the hematology products and services market in 2018
North America is estimated to account for the largest share of the market in 2018. This can be attributed to the rising incidence of patients suffering from blood disorders, growing prevalence of target diseases, and the rising demand for blood transfusions increasing the demand for hematology testing in the region.

The major players of the global Hematology Analyzers and Reagents Market are Sysmex (Japan), Danaher (US), Nihon Kohden (Japan), Siemens (Germany), Abbott Laboratories (US), Boule Diagnostics (Sweden), HORIBA (Japan), Bio-Rad Laboratories (US), BioSystems (Spain), Diatron (Hungary), Drew Scientific (US), EKF Diagnostics (UK), Mindray (China), Ortho Clinical Diagnostics (US), and Roche (Switzerland).

About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com

Revenue Cycle Management Market Worth 90.43 Billion USD by 2022

Revenue cycle management (RCM) in healthcare industry has fast become a buzzword over the past few years. It enables the healthcare organizations to manage payments, claims processing, and revenue generation, thereby accelerating the whole revenue cycle in an efficient manner. RCM solution begins when a patient enters or schedules an appointment. It automates the whole procedure with initiation of the process by the patient, quick follow ups, determining the eligibility of the patient, collecting their payment, effective tracking of the claims process, and working on rejected claims among others. The rising need for streamlining the whole process has further boosted the demand for RCM solutions, thereby triggering the growth of the RCM market.

 
Browse 104 market data Tables and 31 Figures spread through 168 Pages and in-depth TOC on "Revenue Cycle Management Market".

https://www.marketsandmarkets.com/Market-Reports/revenue-cycle-management-market-153900104.html

Early buyers will receive 10% customization on reports

Regulatory mandates for the adoption of EHR/EMR and government initiatives to boost the adoption of RCM solutions are the major factors driving the adoption of RCM solutions.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=153900104

Based on product, the integrated solutions segment is accounted for the largest share of the market in 2017
On the basis of product, the market is broadly segmented into integrated and standalone solutions. The integrated solutions segment is expected to account for the largest share of the global revenue cycle management market in 2017 and is projected to register the highest CAGR during the forecast period. Growth in this segment can be attributed to the rising adoption of value-based payment systems and the growing demand for cost-saving data management solutions.

Based on function, the claim and denial management segment is accounted for the largest share of the market in 2017
On the basis of function, the market is broadly segmented into claim and denial management, medical billing and coding, patient insurance eligibility check, payment remittance, electronic health record (EHR), clinical documentation improvement (CDI), and others. The claim and denial management segment is expected to account for the largest share of the global revenue cycle management market in 2017 and is expected to witness the highest CAGR during the forecast period. The growing demand for claims and denial management due to the dynamic reimbursement structure and the increasing instances of claim denials are the major factors driving the growth of this segment.

North America is expected to dominate the market in 2017
In 2017, North America is expected to account for the largest share of the global revenue cycle management market. The large share of this regional segment can be attributed to stringent legislative and accreditation requirements regarding healthcare, high adoption rate of HCIT technologies, and regulatory requirements regarding patient safety. Europe is expected to account for the second-largest share of the revenue cycle management market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=153900104

Key Market Players:
The key players in the Global Revenue Cycle Management Market are McKesson (US), Cerner (US), Quest Diagnostics (US), Allscripts Health Solutions (US), and athenahealth (US).

Browse Related Reports:

North American Healthcare IT Market by Product (EHR, RIS, PACS, VNA, CPOE, mHealth, Telehealth, Healthcare analytics, Supply Chain Management, Revenue Cycle Management, CRM, Claims Management) by End User (Provider, Payer ) - Forecast to 2020 

For more Insights: https://www.marketsandmarkets.com/Market-Reports/north-america-healthcare-it-market-1190.html

 

About MarketsandMarkets™  
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Shelly
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com

 

Burn Care Market for Full-Thickness Burns to Witness Highest Growth in Asia

According to a new market research report " Burn Care Market by Product (Advanced (Alginate, Collagen, Hydrocolloid, Hydrogel), Biologics, Traditional), Depth (Minor, Partial-thickness, Full-thickness Burn), End-Users (Hospitals (Inpatient, Outpatient), Physician Clinics, Homecare) - Forecast to 2021".

According to the latest WHO study, there are around 3800 people suffers from burn injuries in U.S. And its rate is increasing due to increase in industrialization and population across the world. Many victims suffer from burns which are of three type’s i.e First, Second and Third Degree burns. In most of the cases, we found minor burns, followed by second degree (partial thickness burns) and third degree (Full thickness burns) which requires proper treatment and regular check-ups. 

Browse 140 market data Tables and 107 Figures spread through 187 Pages and in-depth TOC on "Burn Care Market"

http://www.marketsandmarkets.com/Market-Reports/burn-care-market-247121470.html

These treatments include skin grafting, regular dressing and many more, based on the depth and size of burns. In the cases of Third degree burns, emergency hospitalization required along with treatments like anesthesia, oxygenation, etc required to relief the pain and make the patients survive. Although, around 60% cases, burn victims dies out of pain and organ failure. We can relate it with another burn type called "fourth degree burns" which affects the victims' interior parts like bones and tendons and has lower chances of victim to survive depending upon the burned area.

Market growth can be attributed to factors such as rising incidence of burns, increasing healthcare expenditure, favorable government initiatives, increasing number of emergency centers and burn units, and growing awareness regarding treatment options.

In this report, the burn care market has been segmented on the basis of product, depth of burn, end user, and region. 

On the basis of end users, the burn care market is segmented into hospitals, physician clinics, home care and other end users.

Based on regions, the burn care market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to account for the largest share of the market in 2016.

Ask for PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=247121470

Key players in the Burn Care Market include Smith & Nephew plc (U.K.), Mölnlycke Health Care (Sweden), Convatec Inc. (U.K.), Acelity L.P. (U.S.), Coloplast A/S (Denmark), Derma Sciences, Inc. (U.S.), Medtronic (Ireland), and 3M Company (U.S.).